drugset / Trial / NCT00563849
Leflunomide + Methotrexate in Rheumatoid Arthritis
NaSingle-groupOpen-labelTreatment
Summary
To determine the efficacy and safety of the combination of leflunomide and methotrexate for treating active rheumatoid arthritis (RA) in an open noncomparative multicenter trial.
Timeline
- Start
- 2003-05
- Primary completion
- —
- Completion
- 2004-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Leflunomide | Small molecule | 10 mg | — |
| Subject | Methotrexate | Small molecule | 15 mg | — |